Beta Drugs Limited (NSE:BETA)

India flag India · Delayed Price · Currency is INR
1,670.20
-69.85 (-4.01%)
At close: Nov 7, 2025
-4.01%
Market Cap17.06B
Revenue (ttm)3.90B
Net Income (ttm)418.99M
Shares Out10.09M
EPS (ttm)53.63
PE Ratio31.51
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume14,385
Average Volume3,801
Open1,725.00
Previous Close1,740.05
Day's Range1,620.00 - 1,725.00
52-Week Range1,429.52 - 2,215.24
Beta-0.35
RSI35.86
Earnings DateNov 4, 2025

About Beta Drugs

Beta Drugs Limited develops, manufactures, and sells anti-cancer bulk drugs and finished dosages in India. The company offers cosmeceutical and oncology products. It also manufactures active pharmaceutical ingredients (API) and pharmaceutical formulation intermediates (PFI). The company exports its products. Beta Drugs Limited was founded in 1985 and is based in Panchkula, India. [Read more]

Industry Biological Products, Except Diagnostic Substances
Founded 1985
Employees 399
Stock Exchange National Stock Exchange of India
Ticker Symbol BETA
Full Company Profile

Financial Performance

In 2024, Beta Drugs's revenue was 3.62 billion, an increase of 22.54% compared to the previous year's 2.96 billion. Earnings were 424.19 million, an increase of 16.42%.

Financial Statements

News

There is no news available yet.